172913-96-1

Basic information

• Product Name: (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate
• Synonyms: (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate;Carbamic acid, N-[(3S)-6-oxo-3-piperidinyl]-, 1,1-dimethylethyl ester
• CAS NO: 172913-96-1
• Molecular Formula: C₁₀H₁₈N₂O₃
• Molecular Weight: 214.263
• Mol File: 172913-96-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate(172913-96-1)
• EPA Substance Registry System: (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate(172913-96-1)

Safety Data

• Hazardous Substances Data: 172913-96-1(Hazardous Substances Data)

Usage

General Description

"(R)-tert-butyl 6-oxopiperidin-3-ylcarbamate" is a chemical compound that belongs to the class of carbamates. It is a derivative of piperidine and contains a tert-butyl group as well as a carbamate functional group. (R)-tert-butyl 6-oxopiperidin-3-ylcarbamate has potential applications in pharmaceutical research, particularly in the development of new drugs targeting the central nervous system due to its structural similarities with existing bioactive compounds. Its unique structure and properties make it a valuable building block for the synthesis of various drugs and organic compounds. Additionally, it may also have potential uses as a reagent in organic synthesis and chemical research.

Upstream product

• 45214-91-3 (2S)-2-[(tert-butoxy)carbonylamino]-4-(methoxycarbonyl)butanoic acid 
• 130223-39-1 methyl 4-<(tert-butyloxycarbonyl)amino>-5-(O-tosyl)pentanoate 
• 330680-83-6 methyl (4S)-5-azido-4-[(tert-butoxycarbonyl)amino]pentanoate 
• 251987-13-0 (4S)-N-benzyloxy-4-(N-tert-butoxycarbonyl)amino-5-[(1-ethoxy)ethoxy]pentanamide 
• 251987-04-9 (5S)-1-tert-butoxycarbonyl-5-(1-ethoxy)ethoxymethyl pyrrolidin-2-one 
• 91229-96-8 (4S)-N-benzyloxy-4-(N-tert-butoxycarbonyl)amino-5-hydroxypentanamide 
• 126587-35-7 methyl (4S)-4-[(tert-butoxy)carbonylamino]-5-hydroxypentanoate 
• 515863-25-9 (S)-tert-butyl 2-(azidomethyl)-5-oxopyrrolidine-1-carboxylate 
• 93288-20-1 [(2S)-5-oxopyrrolidin-2-yl]methyl methanesulfonate 
• 17342-08-4 (S)-Pyroglutaminol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 91229-98-0 1-(benzyloxy)-5-<(tert-butyloxycarbonyl)amino>-piperidone 
• 672883-28-2 4-tert-butoxycarbonylamino-5-methanesulfonyloxy-pentanoic acid methyl ester 

Downstream Products

• 672883-95-3 4-(S)-amino-δ-valerolactam hydrochloride 
• 1527525-47-8 tert-butyl N-[(3S)-1-[3-methyl-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]-6-oxo-3-piperidyl]carbamate 
• 1527523-89-2 (5S)-5-amino-1-[3-methyl-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]piperidin-2-one 
• 1527525-46-7 tert-butyl N-[(3S)-1-(6-chloro-3-methyl-2-pyridyl)-6-oxo-3-piperidyl]carbamate 
• 1133960-11-8 (S)-benzyl 5-(tert-butoxycarbonyl)amino-2-oxopiperidine-1-carboxylate 
• 1133960-10-7 (S)-tert-butyl 5-(tert-butoxycarbonylamino)-2-oxopiperidine-1-carboxylate 
• 154148-70-6 (S)-5-aminopiperidin-2-one 
• 2365230-46-0 (S)-6,6-dimethylpiperidin-3-amine 

Relevant articles and documents

TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.

NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.

Diastereoselective synthesis of enantiopure differentially protected cis-4,5-diaminopiperidin-2-one through intramolecular transamidation

The diastereoselective synthesis of enantiopure differentially protected cis-4,5-diaminopiperidin-2-one was achieved by means of conjugate addition of ammonia to an unsaturated γ-lactam and transamidation reaction with ring expansion as the main steps.